Cargando…
Efficacy and safety of a biodegradable polymer sirolimus-eluting stent in primary percutaneous coronary intervention: a randomized controlled trial
INTRODUCTION: With long-term follow-up, whether biodegradable polymer drug-eluting stents (DES) is efficient and safe in primary percutaneous coronary intervention (PCI) remains a controversial issue. This study aims to assess the long-term efficacy and safety of DES in PCI for ST-segment elevation...
Autores principales: | Li, Qiang, Tong, Zichuan, Wang, Lefeng, Zhang, Jianjun, Ge, Yonggui, Wang, Hongshi, Li, Weiming, Xu, Li, Ni, Zhuhua, Yang, Xinchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902723/ https://www.ncbi.nlm.nih.gov/pubmed/24482648 http://dx.doi.org/10.5114/aoms.2013.39793 |
Ejemplares similares
-
Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
por: Zhang, Haijun, et al.
Publicado: (2016) -
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020) -
The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
por: Chisari, Alberto, et al.
Publicado: (2016) -
Performance evaluation of biodegradable polymer sirolimus and ascorbic acid eluting stent systems
por: Jo, Won-Il, et al.
Publicado: (2022) -
Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
por: Zbinden, Rainer, et al.
Publicado: (2016)